坦基拉酶:一个有前途的治疗点,具有类作用
Vrunda Sagathia1, Chirag Patel2, Jayesh Beladiya1
1Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, 380009, Gujarat, India.
Naunyn-Schmiedeberg's archives of pharmacology
|June 20, 2023
概括
坦基酶酶 (TNKS1/TNKS2) 调节蛋白质降解,在细胞周期,端粒维护和信号通路中至关重要. 向坦基酶为癌症和糖尿病等疾病提供了潜在的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 坦基拉酶酶 (TNKS1和TNKS2) 是多 (ADP-ribose) 聚合酶 (PARP) 家族的一部分.
- 它们在多ADP-ribosylation中发挥作用,通过ubiquitin-proteasome系统影响蛋白质降解.
研究的目的:
- 为了审查坦基拉斯的结构和功能.
- 阐明坦基拉斯在各种疾病中的作用.
- 为了总结针对坦基拉斯的药物的实验证据.
主要方法:
- 科学文章和实验数据的文献评论.
- 坦基拉酶结构,功能和参与疾病的分析.
- 收集针对坦基拉斯的治疗剂的数据.
主要成果:
- 坦基酶参与细胞循环,端粒维护,Wnt和胰岛素信号传递.
- 坦基拉酶活性失调与癌症,肥胖,糖尿病和其他疾病有关.
- 目前正在研究针对坦基拉斯的各种治疗策略.
结论:
- 坦基拉酶是关键的调节者,对人类健康和疾病有重大影响.
- 向坦基拉斯是一种有希望的治疗途径,用于多种疾病.
- 对坦基拉酶抑制剂的进一步研究可能会导致新的治疗选择.
更多相关视频
06:56Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
424
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
